BG Medicine up big in today's trading

Investors are gobbling up nano cap BG Medicine (BGMD +15.6%) today. Shares are up 16% on 6x normal volume.

The current up trend began on December 12 after the company announced a 69% increase in Medicare reimbursement for its Gelectin-3 blood test.

Since then, the firm announced positive results for the automated version of the test and met NASDAQ Capital Markets' listing requirements.

Consensus revenue estimates for 2013 and 2014 are $4.1M and $6.2M, respectively.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs